Standard newborn screening can detect dozens of inherited diseases, but genomics technology enables testing for hundreds of them. A North Carolina program evaluating the feasibility of bringing genomics to newborn screening is expanding with an initial goal of testing 5,000 babies in the next year.
New research indicates that the social support a patient gets when text messaging before surgery decreases the need for additional pain management.
RTI International has named one of its own to become its next president and CEO. Researcher and clinical psychologist Wayne Holden will become just the fourth president to lead the global research institute since it was founded in 1958. Holden will succeed current CEO Victoria Haynes, who announced last year her plans to retire after […]
RTI International has won a nearly $60 million federal contract to assess just how effective certain Centers for Disease Control and Prevention public health programs really are. Research Triangle Park, North Carolina-based RTI will evaluate the CDC’s Community Transformation Grant program, or CTG, which provides grants that implement policy or environmental changes targeting chronic diseases, […]
A senior toxicologist at RTI International whose expertise includes research on bisphenol A, or BPA, a chemical found in food containers and household products, will now advise the National Sanitation Foundation International on reproductive and toxicology issues. Rochelle “Shelley” Tyl, a distinguished fellow in developmental and reproductive toxicology at RTI, a nonprofit research institute […]
The CED Biotech/Life Science Conference didn’t have an official theme, but if it did, it could have been "think early." What the more than 1,000 in attendance got was a steady, instructional drumbeat telling them to think about facing important decisions for their companies and their research and development at earlier stages than they’re accustomed.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Centers for Disease Control and Prevention veteran Michael McGeehin has been chosen to lead a new program at RTI International researching public health issues, such as how people are affected by flooding, drought, higher readings of ground-level ozone and food and water-borne diseases. RTI is a non-profit research institute based in North Carolina’s Research Triangle Park.
